DrugManagementForum.com

FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates

This is a discussion on FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates within the FDA News forum, part of the Industry News and Updates category; FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates More......


Go Back   DrugManagementForum.com > Industry News and Updates > FDA News

Register Help Members List Mark Forums Read

Rate This Thread - FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates.

Only registered members can vote. To rate this thread register here.

Reply

 

Thread Tools
  #1 (permalink)  
Old 11-12-2008, 10:48 AM
automated news aggregator
 
Join Date: Jan 2008
Posts: 978
Default FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates

FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates

More...
Reply With Quote
Reply


Thread Tools
Display Modes


Similar Threads

Thread Thread Starter Forum Replies Last Post
FDA issues an updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler). industry_news FDA News 0 10-07-2008 10:37 AM
Epoetin alfa - Early Communication about an Ongoing Safety Review industry_news FDA News 0 09-26-2008 11:42 AM
FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. industry_news FDA News 0 08-22-2008 02:44 PM
FDA issues an Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Re industry_news FDA News 0 06-07-2008 06:30 PM
FDA issues an Early Communication about an Ongoing Safety Review for Botox industry_news FDA News 0 02-26-2008 02:30 PM


© 2008 DrugManagementForumpowered by
Informaceutica - Drug Management Information Company

All times are GMT -4. The time now is 12:48 PM.